Previous close | 51.50 |
Open | 51.80 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 51.80 - 51.80 |
52-week range | 46.50 - 85.60 |
Volume | |
Avg. volume | 1,018 |
Market cap | 7.594M |
Beta (5Y monthly) | 0.93 |
PE ratio (TTM) | 0.20 |
EPS (TTM) | 2.58 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Villers-lès-Nancy, 6 February 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 revenue: €219.7m, +2.6% Equasens Group reported growth in annual revenue, despite an unfavourable comparison base from the Ségur French Digital Healthcare investment programme combined with difficult economic conditions, particularly in the pharmacy sector. Consolidated revenueIn €m20232022Change2023 / 2022Q156.349.414.0% (*)Q256.4 54.2 4.0%Q3 50.1 50.10.0%Q457.060.4-5.5%12 month YTD 219.7 (**)214.1 +2.6% (*) Strong growth i
Villers-lès-Nancy, 2 January 2024 - 6:00 p.m. (CET) PRESS RELEASE Acquisition of a majority stake in DIGIPHARMACIE, An expert in digital and invoice management solutions for pharmacies With this acquisition, Equasens Group: Strengthens its offering of solutions for healthcare professionals and consolidates its position as a leading European provider of digital healthcare solutions.Addresses the growing demand for digital invoicing solutions following the introduction of new obligations in France
Villers-lès-Nancy, 27 December 2023 - 6:00 p.m. (CET)PRESS RELEASE Changes in the Equasens Group Executive Committee Equasens Group, a leading healthcare software publisher (Euronext Paris™ - Compartment A - ISIN: FR 0012882389 - Ticker: EQS), announces a change in its Executive Committee with effect from 1 January 2024. Damien VALICON becomes the new head of the Pharmagest Division Damien VALICON, currently manager of the Medical Solutions Division, will now head up the Pharmagest Division. In